Insider sale
DYNE THERAPEUTICS, INC.
$12.42M
478.38K shares
What this filing means
ATLAS VENTURE OPPORTUNITY FUND II, L.P. plans to sell 478.38K shares of DYNE THERAPEUTICS, INC. valued at approximately $12.42M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/14/2026ACC: 0001628280-26-057188
10% Owner
Since Dec 2022
478.38K
Shares to sell
$12.42M
Approx. market value
478.38K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
12/12/2022
478.38KTotal acquired478.38K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/12/2022 | Private Placement Cash | 478.38K | — |
| Total | 478.38K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
478.38K
Market value
$12.42M
8/14/2026
Total
Units
478.38K
Value
$12.42M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/14/2026 | 478.38K | $12.42M | Nasdaq | Planned |
| Total | 478.38K | $12.42M | ||